CardioVascular BioTherapeutics (fka CVBT)

[walhall]

Venturis Therapeutics Zombie Chronicles: Patent Edition

The patent zombies are out in full force continuing to put forward their zombie-eaten, brain-dead arguments about how valuable the patents are at Venturis Therapeutics.

Let's yet again re-state a crucial fact: There is not one Wall Street analyst that values a development-stage biotech company primarily or even secondarily through the prism of patents. NOT ONE.

Do Wall Street analysts value biotech companies that have FDA-approved products on the market and active revenue streams through a prism (but not the only one) of patents? Yes, they do. But a development-stage zombie biotech company that has zero revenues, zero approved drugs, zero ongoing clinical trials, and is insolvent? HELL NO!

That Venturis Therapeutics's supporters feel the need to grossly misrepresent how things work shows one of three things: (1) they're idiots; or (2) they think everyone else is stupid; or (3) zzzombie....zzzombie.....zzzombie....zzzombie.....zzzzzzz.....

But let's not forget that ZOMBIE COMPANIES only talk about things that are irrelevant. What zombie companies don't talk about is the only thing that matters for a development-stage biotech company: running clinical trials. Venturis Therapeutics has not run a single clinical trial in 14 years (and counting). Why don't we talk about this, since it's the only thing that matters?

Here's more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377